This inventor holds 28 USPTO granted patents and 12 published patent applications, plus 3 CIPO patents and 5 EPO patents, primarily in Antibody Molecules. Top assignees: Visterra, Inc., Massachusetts Institute of Technology, Momenta Pharmaceuticals, Inc.. Active years: 2007-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Belmont, MA (US) (2007 - 2011)
- Waltham, MA (US) (2007 - 2024)
Company Filing History:
13 out of 38 
8 out of 8,578 
6 out of 121 
Years Active: 2007-2025
Areas of Expertise:
Title: James R. Myette: Innovating in Antibody Research
Introduction: James R. Myette, based in Waltham, MA, is a prominent inventor known for his significant contributions to the field of antibody research. With an impressive portfolio of 27 patents, Myette's work has had a profound impact on medical diagnostics and treatment.
Latest Patents: Among his latest innovations are two notable patents. The first is a method of using antibody molecules to detect a proliferation-inducing ligand (APRIL). This patent discloses antibody molecules that specifically bind to APRIL, offering potential applications in treating, preventing, and diagnosing disorders such as IgA nephropathy. The second patent pertains to antibody molecules that bind to the dengue virus, encompassing all four serotypes (DV-1, DV-2, DV-3, and DV-4). These antibody molecules are developed for use in treating, preventing, and diagnosing dengue virus infections.
Career Highlights: Myette has showcased his innovative prowess while working with reputable organizations such as Visterra, Inc. and the Massachusetts Institute of Technology. His experience in these institutions has allowed him to refine his research and contribute to advancements in the field.
Collaborations: Throughout his career, Myette has collaborated with notable professionals, including Zachary Shriver and Gregory Babcock. These collaborations have played a significant role in fostering innovation and driving research progress in antibody technology.
Conclusion: James R. Myette continues to be a pioneering figure in the world of antibody research. His dedication to innovation and his extensive patent portfolio underscore his commitment to improving medical diagnostics and treatment options. As he progresses in his career, Myette's contributions will undoubtedly shape the future of biomedical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile